Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1957 Jul 13;2(5036):78–80. doi: 10.1136/bmj.2.5036.78

Treatment of Schizophrenia

J Lomas
PMCID: PMC1961762  PMID: 13436861

Full text

PDF
80

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAKER A. A., THORPE J. G. A research method to assess a new tranquilizing drug. J Ment Sci. 1956 Oct;102(429):790–795. doi: 10.1192/bjp.102.429.790. [DOI] [PubMed] [Google Scholar]
  2. BIEZANEK A., GORE C. P. Agranulocytosis during treatment with pacatal. Lancet. 1956 Nov 24;271(6952):1081–1081. doi: 10.1016/s0140-6736(56)90213-6. [DOI] [PubMed] [Google Scholar]
  3. BOARDMAN R. H., LOMAS J., MARKOWE M. Insulin and chlorpromazine in schizophrenia; a comparative study in previously untreated cases. Lancet. 1956 Sep 8;271(6941):487–491. doi: 10.1016/s0140-6736(56)91972-9. [DOI] [PubMed] [Google Scholar]
  4. HIOB J., HIPPIUS H. Uber die Behandlung von Psychosen mit dem Phenothiazinderivat Pacatal. Med Klin. 1955 Oct 14;50(41):1746–1748. [PubMed] [Google Scholar]
  5. HORATZ K. Die potenzierte Narkose ohne und mit Unterkühlung; ihre Vorteile, Grenzen und Gefahren. Munch Med Wochenschr. 1954 Apr 16;96(16):426–429. [PubMed] [Google Scholar]
  6. KING A., MITCHELL P. H., SYKES P. Effects of pacatal on symptoms in chronic psychotic female in-patients. Br Med J. 1957 Jan 26;1(5012):204–207. doi: 10.1136/bmj.1.5012.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. KLINE N. S., JACOB G. M. Use of pacatal (N-methylpiperidyl-(3)-methylphenothiazine) in psychiatric patients. Am J Psychiatry. 1955 Jul;112(1):63–63. doi: 10.1176/ajp.112.1.63. [DOI] [PubMed] [Google Scholar]
  8. KOPF R. Phenthiazinderivaternes farmakologi, med specielt henblik på N-methyl-piperidyl-3-methylphenthiazin (lacumin). Nord Med. 1955 Dec 1;54(48):1779–1782. [PubMed] [Google Scholar]
  9. LABHARDT F. Die Largactiltherapie bei Schizophrenien und anderen psychotischen Zuständen. Schweiz Arch Neurol Psychiatr. 1954;73(1-2):309–338. [PubMed] [Google Scholar]
  10. LOMAS J., BOARDMAN R. H., MARKOWE M. Complications of chlorpromazine therapy in 800 mental-hospital patients. Lancet. 1955 Jun 4;268(6875):1144–1147. doi: 10.1016/s0140-6736(55)90642-5. [DOI] [PubMed] [Google Scholar]
  11. LOMAS J. Uses of chlorpromazine in mental hospital patients. Br Med J. 1955 Apr 9;1(4918):879–882. doi: 10.1136/bmj.1.4918.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MEYER H. H. Die Winterschlafbehandlung in der Psychiatrie und Neurologie. Dtsch Med Wochenschr. 1953 Aug 14;78(33-34):1097–1100. doi: 10.1055/s-0028-1114881. [DOI] [PubMed] [Google Scholar]
  13. NIESCHULZ O., POPENDIKER K., HOFFMANN I. Weitere pharmakologische Untersuchungen über N-Methyl-piperidyl-(3)-methyl-phenothiazin. Arzneimittelforschung. 1955 Dec;5(12):680–695. [PubMed] [Google Scholar]
  14. VAUGHAN G. F., LEIBERMAN D. M., COOK L. C. Chlorpromazine in psychiatry. Lancet. 1955 May 28;268(6874):1083–1087. doi: 10.1016/s0140-6736(55)90587-0. [DOI] [PubMed] [Google Scholar]
  15. WENDEROTH H., LENNARTZ H. Agranulocytose nach Phenothiazin. Med Klin. 1955 May 13;50(19):818–820. [PubMed] [Google Scholar]
  16. WERENBERG H. Lacuminterapi ved svaere sindsygdomme. Nord Med. 1955 Dec 1;54(48):1787–1789. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES